MedTrace Logo

Transurethral Prostate Enucleation in Surveillance Protocol for Low Risk Prostate Cancer

NCT05631080 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-11-30

No results posted yet for this study

Summary

We will compare oncological and functional outcomes of anatomical endoscopic enucleation of the prostate (AEEP) versus continued medical treatment in low-risk prostate cancer patients for whom an active surveillance protocol was selected.

Conditions

  • Prostate Cancer Stage I
  • Bladder Outlet Obstruction

Interventions

PROCEDURE

Anatomical Endoscpic enucleation of the Prostate

Transurethral endoscopic enucleation of the prostate adenoma

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Ahmed Elshal, MD · Mansoura University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2022-09-30
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05631080 on ClinicalTrials.gov